“…The patients were mostly older than the controls, but we have not found age to be a significant factor in receptor studies. Previous investigations of granulocyte function in patients with myelomatosis have demonstrated impairment due to serum or plasma factors (3,5 ) . Hopen et al (4) found myelomatosis serum to decrease granulocyte adhesion and migration; this effect could not, however, be correlated to the decreased phagocytosis by myelomatosis granulocytes, as measured by chemiluminescence.…”